Research Article
Development and Validation of a Discriminating In Vitro Dissolution Method for Oral Formulations Containing Satranidazole
Table 7
Method precision/repeatability.
| | Sample number | % cumulative release at 60 min | | Day 1 | Day 2 | | Analyst 1 | Analyst 2 |
| | 1 | 87.09 | 88.34 | | 2 | 86.23 | 89.23 | | 3 | 87.24 | 87.89 | | 4 | 88.78 | 86.21 | | 5 | 87.65 | 87.47 | | 6 | 88.94 | 87.01 | | Mean | 87.655 | 87.691 | | Standard deviation (SD) | 1.042 | 1.052 | | Relative standard deviation (% RSD) | 1.189 | 1.199 | | Mean | 87.673 | | Standard deviation (SD) | 0.999 | | Relative standard deviation (% RSD) | 1.139 |
|
|
